🇺🇸 FDA
Patent

US 9340546

Compounds useful as inhibitors of ATR kinase

granted A61PA61P1/02A61P1/04

Quick answer

US patent 9340546 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 12 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61P, A61P1/02, A61P1/04, A61P1/16, A61P1/18